Search

everythinglearnresearchcommunity

for

Search:↓

Enzymes play crucial roles in metabolism, health, and disease management.

Sebocytes play a key role in controlling androgen levels in human skin.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The study created a new method to test drugs that affect hormone processing in skin.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Both drugs lower DHT levels, with GI198745 being more effective.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Testosterone's muscle-building effects do not require its conversion to DHT.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.